Eric A. Secemsky/LinkedIn
Sep 17, 2025, 16:32
Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
Endovascular Today posted on LinkedIn:
”Eric A. Secemsky offers his thoughts on how the pause in paclitaxel use impacted the care of patients with lower extremity arterial occlusive disease and discusses observed clinical effects during that period. ”
Read more here.
Title: Exploring the Effects of the Paclitaxel Pause
Author: Eric A. Secemsky
Stay updated with Hemostasis Today.
-
Feb 3, 2026, 10:53Aurelio Maggio: The Final Chapter of Our Journey Through Thalassemia
-
Feb 3, 2026, 10:40Pedro Perez: Post-Thrombectomy DVT Recovery in 2026 – Closing the Loop on Outcomes
-
Feb 3, 2026, 10:26Ryan Williams: This Article Brings to Light The Complexity of PRP…
-
Feb 3, 2026, 10:05Tiago Lopes: Can AI Predict Immune Reactions of New Drugs? Yes!
-
Feb 3, 2026, 09:51Rucha Patil Reflects on 49th MHG Annual Conference and Essence of ASH 2025
-
Feb 3, 2026, 09:37Grigoris Gerotziafas on VTE in MM and BCMA: We Are Pleased to Announce Our New Systematic Review
-
Feb 3, 2026, 09:24Early-Bird Registration for the WFH 2026 World Congress is Now Open
-
Feb 3, 2026, 09:15Joshua Bernstock: Prehospital Stroke Triage Has Hit a Ceiling
-
Feb 3, 2026, 09:00A Major Highlight of 2025 and Honour For Me: Ashkan Shoamanesh at Huashan International Stroke Conference